메뉴 건너뛰기
Canadian Journal of Ophthalmology
Volumn 44, Issue 1, 2009, Pages 109-110
False-negative apraclonidine testing in acute Horner syndrome
Author keywords

[No Author keywords available]
Indexed keywords

APRACLONIDINE; COCAINE;
EID: 59849087075     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-162     Document Type: Letter
Times cited : (20)
References (8)
  • 1
    • 0015104637 scopus 로고
    • Adrenergic mydriasis in Horner's syndrome: Hydroxyamphetamine test for diagnosis of postganglionic defects
    • Thompson HS, Mensher JH. Adrenergic mydriasis in Horner's syndrome: hydroxyamphetamine test for diagnosis of postganglionic defects. Am J Ophthalmol 1971;72:472-80.
    • (1971) Am J Ophthalmol , vol.72 , pp. 472-480
    • Thompson, H.S.1    Mensher, J.H.2
  • 3
    • 0043063858 scopus 로고    scopus 로고
    • The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome
    • Brown S, Aouchiche R, Freedman K. The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome. Arch Ophthalmol 2003;121:1201-3.
    • (2003) Arch Ophthalmol , vol.121 , pp. 1201-1203
    • Brown, S.1    Aouchiche, R.2    Freedman, K.3
  • 4
    • 0842283899 scopus 로고    scopus 로고
    • The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients
    • Bacal D, Levy S. The use of apraclonidine in the diagnosis of Horner syndrome in pediatric patients. Arch Ophthalmol 2004;122:276-9.
    • (2004) Arch Ophthalmol , vol.122 , pp. 276-279
    • Bacal, D.1    Levy, S.2
  • 5
    • 27344437363 scopus 로고    scopus 로고
    • The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis
    • Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Br J Ophthalmol 2005;89:1442-4.
    • (2005) Br J Ophthalmol , vol.89 , pp. 1442-1444
    • Koc, F.1    Kavuncu, S.2    Kansu, T.3    Acaroglu, G.4    Firat, E.5
  • 6
    • 33748858719 scopus 로고    scopus 로고
    • Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination
    • Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination. Am J Ophthalmol 2006;142:469-74.
    • (2006) Am J Ophthalmol , vol.142 , pp. 469-474
    • Chen, P.L.1    Hsiao, C.H.2    Chen, J.T.3    Lu, D.W.4    Chen, W.Y.5
  • 7
    • 33745895308 scopus 로고    scopus 로고
    • Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients
    • Chen PL, Chen JT, Lu DW, Chen YC, Hsaio CH. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of Horner syndrome in pediatric patients. J Ocular Pharm Ther 2006;22:182-7.
    • (2006) J Ocular Pharm Ther , vol.22 , pp. 182-187
    • Chen, P.L.1    Chen, J.T.2    Lu, D.W.3    Chen, Y.C.4    Hsaio, C.H.5
  • 8
    • 34250197861 scopus 로고    scopus 로고
    • Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants
    • Watts P, Satterfield D, Lim MK. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. J AAPOS 2007;11:282-3.
    • (2007) J AAPOS , vol.11 , pp. 282-283
    • Watts, P.1    Satterfield, D.2    Lim, M.K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.